Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis (Review)
- Authors:
- Zhen‑Hu Ren
- Chen‑Ping Zhang
- Tong Ji
-
Affiliations: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China - Published online on: February 9, 2016 https://doi.org/10.3892/ol.2016.4207
- Pages: 1973-1979
This article is mentioned in:
Abstract
 |
|
Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y and Lemischka IR: Dissecting self-renewal in stem cells with RNA interference. Nature. 442:533–538. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW and Orkin SH: A protein interaction network for pluripotency of embryonic stem cells. Nature. 444:364–368. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E, et al: SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature. 511:246–250. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Power DG, Kelsen DP and Shah MA: Advanced gastric cancer - slow but steady progress. Cancer Treat Rev. 36:384–392. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Koyama-Nasu R, Haruta R, Nasu-Nishimura Y, Taniue K, Katou Y, Shirahige K, Todo T, Ino Y, Mukasa A, Saito N, et al: The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells. Oncogene. 33:2236–2244. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Neumann J, Bahr F, Horst D, Kriegl L, Engel J, Luque RM, Gerhard M, Kirchner T and Jung A: SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer. 11:5182011. View Article : Google Scholar : PubMed/NCBI | |
|
Drilon A, Rekhtman N, Ladanyi M and Paik P: Squamous-cell carcinomas of the lung: Emerging biology, controversies, and the promise of targeted therapy. Lancet Oncol. 13:e418–e426. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L, et al: Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer. 11:422011. View Article : Google Scholar : PubMed/NCBI | |
|
Du L, Yang Y, Xiao X, Wang C, Zhang X, Wang L, Zhang X, Li W, Zheng G, Wang S and Dong Z: SOX2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral Oncol. 47:709–713. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Michifuri Y, Hirohashi Y, Torigoe T, Miyazaki A, Kobayashi J, Sasaki T, Fujino J, Asanuma H, Tamura Y, Nakamori K, et al: High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol Int. 62:684–689. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bray F, Ren JS, Masuyer E and Ferlay J: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ren ZH, Wu HJ, Zhang S, Wang K, Gong ZJ, He ZJ and Peng J: A new surgical strategy for treatment of tongue squamous cell carcinoma based on anatomic study with preliminary clinical evaluation. J Craniomaxillofac Surg. 43:1577–1582. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ren ZH, Wu HJ, Wang K, Zhang S, Tan HY and Gong ZJ: Anterolateral thigh myocutaneous flaps as the preferred flaps for reconstruction of oral and maxillofacial defects. J Craniomaxillofac Surg. 42:1583–1589. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Brinkman BM and Wong DT: Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol. 18:228–233. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB and Zeng MS: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer. 10:102011. View Article : Google Scholar : PubMed/NCBI | |
|
Ren ZH and Wu HJ: Extracapsular spread in cervical lymph nodes. Shiyong Kou Qiang Yi Xue Za Zhi. 28:514–517. 2012.(In Chinese). | |
|
El-Naaj IA, Leiser Y, Shveis M, Sabo E and Peled M: Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients. J Oral Maxillofac Surg. 69:2674–2679. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, et al: SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 41:1238–1242. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, Nishida S, Tanaka T, Fukuta F, Masumori N, Sato N and Tsukamoto T: Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract. Mod Pathol. 26:117–124. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Teodorczyk M, Kleber S, Wollny D, Sefrin JP, Aykut B, Mateos A, Herhaus P, Sancho-Martinez I, Hill O, Gieffers C, et al: CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma. Cell Death Differ. 22:1192–1202. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Goel HL, Gritsko T, Pursell B, Chang C, Shultz LD, Greiner DL, Norum JH, Toftgard R, Shaw LM and Mercurio AM: Regulated splicing of the α6 integrin cytoplasmic domain determines the fate of breastcancer stem cells. Cell Rep. 7:747–761. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature. 414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Pardal R, Clarke MF and Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 3:895–902. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
González-Moles MA, Scully C, Ruiz-Ávila I and Plaza-Campillo JJ: The cancer stem cell hypothesis applied to oral carcinoma. Oral Oncol. 49:738–746. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Boman BM and Wicha MS: Cancer stem cells: A step toward the cure. J Clin Oncol. 26:2795–2799. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hahn WC and Weinberg RA: Rules for making human tumor cells. N Engl J Med. 347:1593–1603. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Wagers AJ and Weissman IL: Plasticity of adult stem cells. Cell. 116:639–648. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC: Gastric cancer originating from bone marrow-derived cells. Science. 306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu AJ and Watt FM: Beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development. 126:2285–2298. 1999.PubMed/NCBI | |
|
Cheng Y, Cheung AK, Ko JM, Phoon YP, Chiu PM, Lo PH, Waterman ML and Lung ML: Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol. 14:442013. View Article : Google Scholar : PubMed/NCBI | |
|
Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S and Puisieux A: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 3:e28882008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Filho MS and Nör JE: The biology of head and neck cancer stem cells. Oral Oncol. 48:1–9. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
González-Moles MA, Bravo M, Ruiz-Avila I, Acebal F, Gil-Montoya JA, Brener S and Esteban F: Ki-67 expression in non-tumour epithelium adjacent to oral cancer as risk marker for multiple oral tumours. Oral Dis. 16:68–75. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yu S, Zhang R, Liu F, Wang H, Wu J and Wang Y: Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem-like side population cells. Oncol Rep. 28:561–566. 2012.PubMed/NCBI | |
|
Zhang P, Zhang Y, Mao L, Zhang Z and Chen W: Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 277:227–234. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Song J, Chang I, Chen Z, Kang M and Wang CY: Characterization of side populations in HNSCC Highly invasive, chemoresistant and abnormal Wnt signaling. PLoS One. 5:e114562010. View Article : Google Scholar : PubMed/NCBI | |
|
Yanamoto S, Kawasaki G, Yamada S, Yoshitomi I, Kawano T, Yonezawa H, Rokutanda S, Naruse T and Umeda M: Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncol. 47:855–860. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Richard V, Nair MG, Santhosh Kumar TR and Pillai MR: Side population cells as prototype of chemoresistant, tumor-initiating cells. Biomed Res Int. 2013:5172372013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhai JM, Yin XY, Hou X, Hao XY, Cai JP, Liang LJ and Zhang LJ: Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma. Dig Dis Sci. 58:1934–1947. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ, Hermans IF and McConnell MJ: Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells. 29:452–461. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Guo D, Xu BL, Zhang XH and Dong MM: Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line cne-2 possess epithelial mesenchymal transition properties in association with metastasis. Oncol Rep. 28:241–247. 2012.PubMed/NCBI | |
|
Wei X, Dombkowski D, Meirelles K, Pieretti-Vanmarcke R, Szotek PP, Chang HL, Preffer FI, Mueller PR, Teixeira J, MacLaughlin DT and Donahoe PK: Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci USA. 107:18874–18879. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wu CP, Zhou L, Xie M, Du HD, Tian J, Sun S and Li JY: Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia. PLoS One. 8:e657502013. View Article : Google Scholar : PubMed/NCBI | |
|
Tabor MH, Clay MR, Owen JH, Bradford CR, Carey TE, Wolf GT and Prince ME: Head and neck cancer stem cells: The side population. Laryngoscope. 121:527–533. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mack B and Gires O: CD44s and CD44v6 expression in head and neck epithelia. PLoS One. 3:e33602008. View Article : Google Scholar : PubMed/NCBI | |
|
Keramari M, Razavi J, Ingman KA, Patsch C, Edenhofer F, Ward CM and Kimber SJ: SOX2 is essential for formation of trophectoderm in the preimplantation embryo. PLoS One. 5:e139522010. View Article : Google Scholar : PubMed/NCBI | |
|
Okumura-Nakanishi S, Saito M, Niwa H and Ishikawa F: Oct-3/4 and SOX2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem. 280:5307–5317. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Evans RD, Perkins VC, Henry A, Stephens PE, Robinson MK and Watt FM: A tumor-associated beta 1 integrin mutation that abrogates epithelial dfferentiation control. J Cell Biol. 160:589–596. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J and Buck DW: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 90:5002–5012. 1997.PubMed/NCBI | |
|
Aruffo A, Stamenkovic I, Melnick M, Underhill CB and Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303–1313. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Felthaus O, Ettl T, Gosau M, Driemel O, Brockhoff G, Reck A, Zeitler K, Hautmann M, Reichert TE, Schmalz G and Morsczeck C: Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. Biochem Biophys Res Commun. 407:28–33. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Faber A, Barth C, Hörmann K, Kassner S, Schultz JD, Sommer U, Stern-Straeter J, Thorn C and Goessler UR: CD44 as a stem cell marker in head and neck squamous cell carcinoma. Oncol Rep. 26:321–326. 2011.PubMed/NCBI | |
|
Oliveira LR, Oliveira-Costa JP, Araujo IM, Soave DF, Zanetti JS, Soares FA, Zucoloto S and Ribeiro-Silva A: Cancer stem cell immunophenotypes in oral squamous cell carcinoma. J Oral Pathol Med. 40:135–142. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Grimm M, Alexander D, Munz A, Hoffmann J and Reinert S: Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells? Target Oncol. 8:189–201. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Nishikawa S, Konno M, Hamabe A, Hasegawa S, Kano Y, Ohta K, Fukusumi T, Sakai D, Kudo T, Haraguchi N, et al: Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. Int J Oncol. 42:1437–1442. 2013.PubMed/NCBI | |
|
Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, Wicha MS and Nör JE: Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 70:9969–9978. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Dong Z, Lauxen IS, Filho MS and Nör JE: Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype. Cancer Res. 74:2869–2881. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Richard V and Pillai MR: The stem cell code in oral epithelial tumorigenesis: 'The cancer stem cell shift hypothesis'. Biochim Biophys Acta. 1806:146–162. 2010.PubMed/NCBI | |
|
Allegra E, Trapasso S, Pisani D and Puzzo L: The role of BMI1 as a biomarker of cancer stem cells in head and neck cancer: A review. Oncology. 86:199–205. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou ZT and Jiang WW: Cancer stem cell model in oral squamous cell carcinoma. Curr Stem Cell Res Ther. 3:17–20. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hayashi S, Tanaka J, Okada S, Isobe T, Yamamoto G, Yasuhara R, Irie T, Akiyama C, Kohno Y, Tachikawa T and Mishima K: Lin28a is a putative factor in regulating cancer stem cell-like properties in side population cells of oral squamous cell carcinoma. Exp Cell Res. 319:1220–1228. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Miranda-Lorenzo I, Dorado J, Lonardo E, Alcala S, Serrano AG, Clausell-Tormos J, Cioffi M, Megias D, Zagorac S, Balic A, et al: Intracellular autofluorescence: A biomarker for epithelial cancer stem cells. Nat Methods. 11:1161–1169. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kokalj Vokač N, Cizmarević B, Zagorac A, Zagradišnik B and Lanišnik B: An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas. Mol Cytogenet. 7:52014. View Article : Google Scholar : PubMed/NCBI | |
|
He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM, Zhao ZL, Liu B, Zhao YF, Zhang WF and Sun ZJ: CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int. 2014:8386322014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM and Albers AE: Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI | |
|
Piao L, Zhang M, Datta J, Xie X, Su T, Li H, Teknos TN and Pan Q: Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. Mol Ther. 20:1261–1269. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Walter V, Yin X, Wilkerson MD, Cabanski CR, Zhao N, Du Y, Ang MK, Hayward MC, Salazar AH, Hoadley KA, et al: Correction: Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS One. 8:e568232014. View Article : Google Scholar | |
|
Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, Maier S, Reischl M, Mikut R, Altorki NK, Moch H, et al: SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol. 24:944–953. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hussenet T, Dali S, Exinger J, et al: SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One. 5:e89602010. View Article : Google Scholar : PubMed/NCBI | |
|
Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G, Rodriguez-Gil Y, Martinez MA, Hernandez L, Hardisson D, Reis-Filho JS and Palacios J: Sox2: A possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol. 20:474–481. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lu W, Feng F, Xu J, et al: QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2. Cancer Biol Ther. 15:1174–1184. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hägerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A and Nistér M: Identification of a SOX2-dependent subset of tumor - and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Neuro Oncol. 13:1178–1191. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bourguignon LY, Wong G, Earle C and Chen L: Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 287:32800–32824. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R and Martin AG: SOX2 expression in breast tumours and activation in breast cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lim YC, Kang HJ, Kim YS and Choi EC: All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway. Eur J Cancer. 48:3310–3318. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Han J, Lu Y, Yang X and Fan M: Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma. Oral Dis. 18:169–177. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SH, Nam HJ, Kang HJ, Kwon HW and Lim YC: Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway. Eur J Cancer. 49:3210–3218. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Züllig L, Roessle M, Weber C, Graf N, Haerle SK, Jochum W, Stoeckli SJ, Moch H and Huber GF: High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. Eur J Cancer. 49:1915–1922. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xu N, Papagiannakopoulos T, Pan G, Thomson JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liu T, Cheng W, Huang Y, Huang Q, Jiang L and Guo L: Human amniotic epithelial cell feeder layers maintain human iPS cell pluripotency via inhibited endogenous microRNA-145 and increased SOX2 expression. Exp Cell Res. 318:424–434. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang CF, Xu XR, Wu TF, Sun ZJ and Zhang WF: Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis. J Oral Pathol Med. 43:492–498. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liu K, Lin B, Zhao M, Yang X, Chen M, Gao A, Liu F, Que J and Lan X: The multiple roles for SOX2 in stem cell maintenance and tumorigenesis. Cell Signal. 25:1264–1271. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Floor SL, Dumont JE, Maenhaut C and Raspe E: Hallmarks of cancer: Of all cancer cells, all the time? Trends Mol Med. 18:509–515. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Christofori G: New signals from the invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Langley RR and Fidler IJ: The seed and soil hypothesis revisited - the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 128:2527–2535. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Comen EA: Tracking the seed and tending the soil: Evolving concepts in metastatic breast cancer. Discov Med. 14:97–104. 2012.PubMed/NCBI | |
|
Comen E, Norton L and Massagué J: Clinical implications of cancer self-seeding. Nat Rev Clin Oncol. 8:369–377. 2011.PubMed/NCBI | |
|
Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, Murase M, Asanuma H, Tamura Y, Morita R, Michifuri Y, et al: SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest. 91:1796–1804. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HJ, Eom DW, Kang GH, Han SH, Cheon GJ, Oh HS, Han KH, Ahn HJ, Jang HJ and Han MS: Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells. Mod Pathol. 26:1123–1131. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hu H, Chang DT, Nikiforova MN, Kuan SF and Pai RK: Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Am J Surg Pathol. 37:1660–1670. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y and Lin B: Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One. 7:e413352012. View Article : Google Scholar : PubMed/NCBI | |
|
Abd El-Maqsoud NM and Abd El-Rehim DM: Clinicopathologic implications of EpCAM and SOX2 expression in breast cancer. Clin Breast Cancer. 14:e1–e9. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T, Liu Y, Li X, Xiang R and Li N: SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network. Cancer Lett. 336:379–389. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Chen S, Sun T, Xu Y, Chen Y, Liu Y, Xiang R and Li N: The transcriptional regulation of SOX2 on FOXA1 gene and its application in diagnosis of human breast and lung cancers. Clin Lab. 60:909–918. 2014.PubMed/NCBI | |
|
Yang F, Gao Y, Geng J, Qu D, Han Q, Qi J and Chen G: Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer. Int J Clin Exp Pathol. 6:2846–2854. 2013.PubMed/NCBI | |
|
Tang XB, Shen XH, Li L, Zhang YF and Chen GQ: SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma. Auris Nasus Larynx. 40:481–486. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Schröck A, Göke F, Wagner P, Bode M, Franzen A, Braun M, Huss S, Agaimy A, Ihrler S, Menon R, et al: Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer. PLoS One. 8:e592012013. View Article : Google Scholar : PubMed/NCBI | |
|
González-Márquez R, Llorente JL, Rodrigo JP, García-Pedrero JM, Álvarez-Marcos C, Suárez C and Hermsen MA: SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma. Hum Pathol. 45:851–857. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Qiao B, He B, Cai J and Yang W: The expression profile of Oct4 and SOX2 in the carcinogenesis of oral mucosa. Int J Clin Exp Pathol. 7:28–37. 2014.PubMed/NCBI | |
|
Lu Y, Futtner C, Rock JR, Xu X, Whitworth W, Hogan BL and Onaitis MW: Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One. 5:e110222010. View Article : Google Scholar : PubMed/NCBI |
